Vicky M. Coyle
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Prevalence and clinical impact of PIK3CA and PTEN alterations from reflex genomic testing of newly diagnosed colorectal cancer: a population-based series.
Journal: Frontiers in oncology
Published: May 22, 2026
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1.
Journal: Journal for immunotherapy of cancer
Published: December 01, 2025
Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.
Journal: Nature metabolism
Published: March 27, 2024
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT.
Journal: Health technology assessment (Winchester, England)
Published: March 21, 2024
The effect of lifestyle interventions on sarcopenia in advanced colorectal cancer: A systematic review.
Journal: Journal of geriatric oncology
Published: January 19, 2024
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).
Journal: Journal of experimental & clinical cancer research : CR
Published: November 09, 2023
Prehabilitation provision and practice in the UK: a freedom of information survey.
Journal: British journal of anaesthesia
Published: October 10, 2023
Early switch to oral antibiotic therapy in patients with low-risk neutropenic sepsis (EASI-SWITCH): a randomized non-inferiority trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: April 25, 2023
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients.
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 10, 2023
A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours.
Journal: British journal of cancer
Published: May 17, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
Journal: Molecular cancer therapeutics
Published: December 09, 2020
Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer.
Journal: NAR genomics and bioinformatics
Published: November 20, 2020
Last Updated: 09/26/2026